Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials
- 8 April 2005
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 100 (1), 119-123
- https://doi.org/10.1016/j.ijcard.2004.11.001
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Drug-eluting stents: an early systematic review to inform policy*1, *2European Heart Journal, 2004
- Six- and Twelve-Month Results From First Human Experience Using Everolimus-Eluting Stents With Bioabsorbable PolymerCirculation, 2004
- Non–Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients With De Novo Coronary LesionsCirculation, 2004
- One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS StentCirculation, 2004
- 1139-61 Is the sirolimus drug eluting stent better than paclitaxel coated stent in “real life” environment?Journal of the American College of Cardiology, 2004
- Analysis of 1-Year Clinical Outcomes in the SIRIUS TrialCirculation, 2004
- Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary StentCirculation, 2004
- Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery LesionsCirculation, 2003
- Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analysesBMJ, 2003
- TAXUS ICirculation, 2003